Steris (FRA:2TG) OCF Margin %: 21.12% (As of Mar. 2026) — 10% Above Median


FRA:2TG Steris PLC FRA:2TG
90 GF Score
Price €183.80
GF Value €238.39
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris OCF Margin %?

Steris FRA:2TG +11.53% 90 OCF Margin % is 21.12% as of Mar. 2026, which is 10% above its 10-year median of 19.17. GuruFocus rates FRA:2TG with a GF Score™ of 90/100 and a GF Value™ of €238.39 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Steris ranks better than 85.4% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Steris's Cash Flow from Operations for the three months ended in Mar. 2026 was €290 Mil. Steris's Revenue for the three months ended in Mar. 2026 was €1,374 Mil. Therefore, Steris's OCF Margin % for the quarter that ended in Mar. 2026 was 21.12%.

As of today, Steris's current OCF Yield % is 6.64%.

The historical rank and industry rank for Steris's OCF Margin % or its related term are showing as below:

FRA:2TG' s OCF Margin % Range Over the Past 10 Years
Min: 16.21   Med: 19.17   Max: 22.6
Current: 22.62


During the past 13 years, the highest OCF Margin % of Steris was 22.60%. The lowest was 16.21%. And the median was 19.17%.

FRA:2TG's OCF Margin % is ranked better than
85.4% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs FRA:2TG: 22.62


Steris OCF Margin % Related Terms


Steris OCF Margin % Historical Data

* Premium members only.

The historical data trend for Steris's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris OCF Margin % Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.21 16.69 18.94 21.03 22.60

Steris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.61 30.19 19.71 19.93 21.12

FRA:2TG vs ZBH, GEHC, DXCM: OCF Margin % Comparison

For the Medical Devices subindustry, Steris's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Steris's OCF Margin % falls into.


FRA:2TG
90GF Score
Steris PLC FRA:2TG
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Steris's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=1160.311/5134.553
=22.60 %

Steris's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=290.121/1373.966
=21.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 21.12% mean?
Steris (FRA:2TG) has a OCF Margin % of 21.12% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Steris and its competitors. This is 10% above median its historical median of 19.17. Over the past decade, Steris' OCF Margin % has ranged from 16.21 to 22.60. According to the industry distribution chart, Steris ranks #119 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 14.6%.
Is Steris' OCF Margin % too high?
Steris' current OCF Margin % of 21.12% is 10% above median its 10-year median of 19.17. Over the past 10 years, this metric has ranged from a low of 16.21 to a high of 22.60. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Steris' value of 21.12% is 260.4% above this industry median. Based on the distribution chart, Steris ranks #119 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Steris has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' OCF Margin % compare to ZBH and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #119 out of 815 companies for OCF Margin %. This places Steris in the top 15% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Steris' value of 21.12% is 260.4% above this benchmark. Historically, Steris' own OCF Margin % has ranged from 16.21 to 22.60 over the past decade. While the company's 10-year median is 19.17 vs. the industry median of 5.86, Steris has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Steris's current OCF Margin % of 21.12% is 260.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Steris and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Steris's current OCF Margin % is 21.12%, which is 10% above median its own 10-year median of 19.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (FRA:2TG) is currently considered Modestly Undervalued. The stock's GF Value™ is €238.39, compared to a current price of €183.80 — trading 22.9% below its estimated fair value. The current OCF Margin % is 21.12%, which is 10% above median its 10-year median of 19.17 and 260.4% above the Medical Devices & Instruments industry median of 5.86. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Steris (FRA:2TG), the current OCF Margin % is 21.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (FRA:2TG) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of €183.80 is trading 22.9% below its estimated GF Value™ of €238.39. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for FRA:2TG:

  • OCF Margin %: 21.12% (10% above median its 10-year median of 19.17)
  • GF Value™: €238.39 vs. price of €183.80 (22.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign
  • Industry Position: 260.4% above the Medical Devices & Instruments median (#119 of 815)

No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Steris Business Description

Other Exchanges STE:USAS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score

Get the complete analysis for FRA:2TG

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€183.80
Price
€238.39
GF Value